Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Yoke Seng Lee
AML
Frederick Locke
lymphoma and immunotherapy
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Huda Salman
CMML
Christine Zhang
AML
Siddhartha Jaiswal
preleukemia
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Areej El-Jawahri
transplant survivorship
Mark Hamilton
DLBCL and CAR-T
Shannon Maude
Immunotherapy for ALL
Julia Paczkowska
immunobiology of Hodgkin's disease
Liling Wan
AML
Srividya Swaminathan
pediatric, immunotherapy
Sigurður Kristinsson
Smoldering myeloma
Tycel Phillips
Mantle Cell Lymphoma
Megan McNerney
AML/MDS
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Susan Schwab
cancer immunology
Nataly Cruz-Rodriguez
T-ALL and metabolism
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Gareth Morgan
smoldering myeloma, MGUS
Grant Challen
preleukemia, leukemia
Jaehyuk Choi
T-cell lymphoma
Jun Qi
Myeloma
Daniel Thomas
Myelofibrosis
Kura Oncology
MLL leukemia, AML
Adam de Smith
pediatric ALL and Down Syndrome
Stacie Dusetzina
Equity in Access
Eirini Papapetrou
blood cancer stem cells
Courtney DiNardo
clinical trials, AML
Riccardo Dalla-Favera
lymphoma (DLBCL)
Peter Klein
MDS
Venkata Lokesh Battula
immunotherapy and AML
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Sarah Tasian
pediatric leukemias
Ruben Carrasco
Myeloma
Neha Mehta-Shah
T-cell lymphoma
Jaroslaw Maciejewski
bone marrow failure
Randall Davis
CLL
Brian Dalton
DNA mutations and myeloid cancers
Philippe Armand
follicular lymphoma
Eugenio Morelli
Myeloma
Martin Dreyling
Mantle Cell Lymphoma
Michael Kharas
leukemia
Nicolas Nassar
pediatric leukemia
George Daley
"off-the-shelf" CAR-T and CAR-NK
Madhav Dhodapkar
multiple myeloma immunotherapy
Carma Bylund
Equity in Access
Jennifer Trowbridge
aging and leukemia
Daniel Lucas
bone marrow and leukemia biology
Tanya Siddiqi
clinical trial access
Rajni Kumari
AML
Hong Wen
AML
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Catherine Smith
leukemia
John DiPersio
trispecific antibody for AML and MDS
Christopher Flowers
clinical trial access
Jeetayu Biswas
splicing in myeloid diseases
Mark Murakami
follicular lymphoma
Wendy Béguelin
follicular lymphoma
Siegfried Janz
Myeloma immunotherapy
Catriona Jamieson
cancer stem cell biology
Marina Konopleva
MDS/AML metabolism
Ricky Johnstone
lymphoma and myeloma
Jianhua Yu
myeloma immunotherapy
Suman Paul
T cell cancers and immunotherapy
Peter Croucher
Multiple Myeloma
Alison Moskowitz
lymphoma therapeutics
Matteo Bellone
Smoldering multiple myeloma
H. Irene Su
Equity in Access
Richard Lock
T-ALL
Bing Carter
p53 mutant AML
Abintus Bio
immunotherapy, in vivo CAR
Jing Fu
myeloma
Fenghuang Zhan
Myeloma and bone disease
Xu Ji
Equity in Access
Paolo Caimi
CAR-T clinical trial for CLL
Inhye Ahn
CLL
Julia Maxson
AML
Maximilian Stahl
AML immunotherapy
Jolanta Grembecka
leukemia therapeutics
Noemí Puig Morón
Myeloma
Frederike Kramer
MPNs
Omar Abdel-Wahab
Hairy cell leukemia
Lindsey Montefiori
pediatric leukemia
Thomas LeBlanc
palliative care
Lucy Godley
preleukemia
Jayna Mistry
aging and leukemias
Reina Takeda
AML
Sahand Hormoz
MPN
Daniel Pollyea
AML
Jeffrey Magee
pediatric AML
Armin Rashidi
gut bacteria and transplant success
Arash Alizadeh
blood cancer biology and diagnosis
Elliot Stieglitz
CMML
Enrico Tiacci
Hairy cell leukemia
Shazia Nakhoda
Equity in Access
Logan Spector
childhood leukemia epidimiology
Tak Mak
Immunotherapy
Daisuke Nakada
preleukemia, leukemia
Simona Colla
Myeloma biology
Keisuke Ito
blood cancer stem cells and MDS metabolism
Alexey Danilov
lymphoma
Taishi Yonezawa
AML
Rong Lu
preleukemia, leukemia
Sham Mailankody
Myeloma immunotherapy clinical trials
George Vassiliou
Leukemia Prevention
Margaret Shipp
lymphoma biology
Christopher Porter
Leukemia, lymphoma
Nirav Shah
CAR-T for lymphoma
Soheil Meshinchi
pediatric AML
Oreofe Odejide
Equity in Access
Andrew Lane
BPDCN
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Stephen Oh
myeloproliferative neoplasms
Caner Saygin
T-ALL
Lakshmi Nayak
brain tumors in lymphoma
Manyi Wei
acute megakaryoblastic leukemia
Luca Busino
DLBCL
John Leonard
lymphoma research
Jonathon Cohen
lymphoma clinical trial access in Georgia
Alieen Rowan
Adult T cell leukemia/lymphoma
Thomas Kipps
Hairy Cell Leukemia
Alex Kentsis
pediatric leukemias
BioInvent International
immunotherapy, indolent NHL, CTCL
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Gaurav Goyal
Erdheim-Chester Disease
Anouchka Laurent
T-cell lymphoma
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Robert Orlowski
(Smoldering) Multiple Myeloma
ImCheck Therapeutics
immunotherapy, AML
Daniel Starczynowski
MDS and AML
Thomas Koehnke
leukemia
Jake Shortt
precision therapy for aggressive lymphomas
Affimed
immunotherapy, HL, PTCL
Lori Muffly
Equity in Access
Timothy Graubert
AML and MDS biology
Sergei Doulatov
Leukemias
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Mala Shanmugam
myeloma
Nicola Vannini
Aging and CAR-T success
Anushree Vichare
Equity in Access
Michael Green
lymphoma biology
Suzanne Lentzsch
Myeloma
Jeremy Baeten
AML
Constellation Pharmaceuticals
myeloproliferative neoplasms
Hao Jiang
DNA biology and leukemia
Coleman Lindsley
AML/MDS
Thorsten Zenz
Hairy cell leukemia
Fahmin Basher
transplant and GvHD
Jenny Wang
AML
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Koichi Takahashi
AML/MDS
F. Lennie Wong
Equity in Access
Ann-Kathrin Eisfeld
Racial diversity in AML
Sriram Sundaravel
AML stem cells
Tomasz Skorski
myeloproliferative neoplasms, AML
Michael Wang
Mantle Cell Lymphoma
Rizwan Romee
Immunotherapy
Jean Koff
Disparities in DLBCL
Ryan Wilcox
T-cell lymphoma
Mark Dawson
B-ALL and CAR-T resistance
Michael Savona
MDS and leukemia
John Crispino
MPNs, myelofibrosis
Cailin Collins
Leukemia and pre-leukemia
Yibin Yang
Lymphoma
Kasey Leger
pediatric blood cancers
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Ana Vujovic
AML
Raymond Mailhot
Equity in Access
Paul Beavis
immunotherapy in myeloma
Pietro Genovese
transplant and AML
Dimericon Therapeutics
dimericons, blood cancer
Alfred Garfall
myeloma immunotherapy
Yiman Liu
Epigenetics and leukemia
Adi Nagler
Bronchiolitis obliterans after transplant
Bingyi Chen
AML immunotherapy
Roland Walter
Antibody-based AML therapies
Christian Steidl
B-cell lymphomas
Jalpa Doshi
Equity in Access
Kymera Therapeutics
protein degraders, TCL, LGLL, AML
Kerry Rogers
CLL
Caron Jacobson
lymphoma and immunotherapy
Carl June
CAR T immunotherapy
Caroline Arber
myeloma CAR-T
Catherine Bollard
pediatric blood cancers and immunotherapy
Steven Horwitz
T-cell lymphomas
Helen Parsons
Equity in Access
Eric Padron
CMML
Marc Seifert
Hairy cell leukemia
Ravindra Majeti
preleukemia, AML
Jonathan Licht
DNA biology, myeloma
Daniel Herranz
T-ALL
Ronald Levy
immunotherapies, COVID-19
Paolo Strati
Non-Hodgkin Lymphoma
Amin Sobh
Myeloma biology
Steven Treon
Lymphomas and Waldenstrom's
Jennifer Woyach
CLL trials
Robert Soiffer
transplantation
Teresa Palomero
Peripheral T-cell Lymphoma
Jennifer Lewis
URM Student
Sisi Chen
leukemia
Leandro Cerchietti
DLBCL
Sheng Li
Aging and AML
Enterome
vaccine, FL, MZL
Nicoletta Cieri
AML and transplantation
Takeshi Sugio
T-cell lymphoma
Anthony Letai
improving CAR-T
Courtney Jones
AML metabolism
Saar Gill
AML immunotherapy
Lev Kats
myeloma and epigenetics
Alec Zhang
myeloma, immunotherapy
Adam Olszewski
Follicular and marginal zone lymphoma
Catherine Diefenbach
DLBCL immunology
Carl Allen
pediatric blood cancers
Brian Walker
smoldering myeloma, MGUS
Stephen Gottschalk
pediatric leukemia and CAR-T
Craig Jordan
AML
Gianpietro Dotti
CAR T and AML
Faron Pharmaceuticals
immunotherapy, MDS
Meng Li
Equity in Access
Lawrence Boise
CART and myeloma
Jessica Stewart
Epstein-barr virus and lymphomas
Stephen Nimer
myeloid cancer biology
Steven Park
follicular lymphoma
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Wendy Stock
T-cell ALL
Mendel Goldfinger
MDS/AML trials for the elderly
Eric Pietras
AML
Britta Will
Leukemia and pre-leukemia
Kimberly Stegmaier
childhood blood cancers
Kirk Schultz
pediatric transplantation
Rgenta Therapeutics
RNA-targeting, blood cancer
Qingyu Luo
BPDCN
Michael Keller
COVID-19, immunotherapy
Liran Shlush
pre-leukemia
Yubin Zhou
peripheral T cell lymphoma
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Jianguo Tao
Mantle Cell Lymphoma
Christopher Booth
BPDCN
Amit Verma
AML/MDS
William Matsui
Myeloma
Piers Patten
COVID-19
Dane Vassiliadis
blood cancer biology
Roberta Zappasodi
lymphoma, immunotherapy
Jonas Jutzi
myeloproliferative neoplasms
Nizar Bahlis
Myeloma immunotherapy
Sam Butterworth
CMML
Markus Muschen
leukemia and lymphoma biology
Bruno Paiva
smoldering myeloma
Tyler Parsons
MPN and AML
Michaela Reagan
Multiple Myeloma
Joachim Yahalom
Lymphoma
Dan Landau
cancer evolution biology
Nitin Jain
CLL
Trent Hall
MDS
Matthew Frank
Lymphoma CART therapy
Marco Ruella
Immunotherapy for T-cell lymphoma
Bailee Kain
AML and African ancestry
Qing Yi
Novel CAR-T
Ravi Bhatia
transplantation
Jing Yang
Myeloma
James Rubenstein
Lymphoma of the Central Nervous System
Pooja Khandelwal
bone marrow transplantation
Christian Marinaccio
MLL leukemias
Justine Kahn
pediatric leukemia and lymphoma
Yan Liu
MDS
Kathleen Sakamoto
pediatric AML
Grzegorz Nowakowski
Clinical trial access
Ari Melnick
epigenetics and lymphoma